(Q37481450)

English

Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs

scientific article published on July 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs (English)

1 reference

Europe PubMed Central

20 August 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

Ichiro Ieiri

1

1 reference

Europe PubMed Central

20 August 2017

Shun Higuchi

2

1 reference

Europe PubMed Central

20 August 2017

Yuichi Sugiyama

3

1 reference

Europe PubMed Central

20 August 2017

language of work or name

0 references

publication date

1 July 2009

1 reference

Europe PubMed Central

20 August 2017

Expert Opinion on Drug Metabolism & Toxicology

1 reference

Europe PubMed Central

20 August 2017

5

1 reference

Europe PubMed Central

20 August 2017

703-729

1 reference

Europe PubMed Central

20 August 2017

7

1 reference

Europe PubMed Central

20 August 2017

Increasing systemic exposure of methotrexate by active efflux mediated by multidrug resistance-associated protein 3 (mrp3/abcc3).

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers.

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

The superfamily of organic anion transporting polypeptides

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Organic anion transporting polypeptides of the OATP/ SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Role of the liver-specific transporters OATP1B1 and OATP1B3 in governing drug elimination

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Transporters and drug therapy: implications for drug disposition and disease

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Genetic polymorphisms of drug transporters: pharmacokinetic and pharmacodynamic consequences in pharmacotherapy

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Contribution of organic anion transporting polypeptide OATP-C to hepatic elimination of the opioid pentapeptide analogue [D-Ala2, D-Leu5]-enkephalin

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Identification of OATP1B3 as a high-affinity hepatocellular transporter of paclitaxel

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Molecular aspects of organic compound transport across the plasma membrane of hepatocytes.

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Single nucleotide polymorphisms in multidrug resistance associated protein 2 (MRP2/ABCC2): its impact on drug disposition

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Exon-intron organization of the human multidrug-resistance protein 2 (MRP2) gene mutated in Dubin-Johnson syndrome

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Genomic structure of the canalicular multispecific organic anion-transporter gene (MRP2/cMOAT) and mutations in the ATP-binding-cassette region in Dubin-Johnson syndrome

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Single nucleotide polymorphisms in ABCC2 and ABCB1 genes and their clinical impact in physiology and drug response

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

A multidrug resistance transporter from human MCF-7 breast cancer cells

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Breast cancer resistance protein (BCRP/ABCG2).

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Characterization of oligomeric human half-ABC transporter ATP-binding cassette G2.

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Breast cancer resistance protein in pharmacokinetics and drug-drug interactions

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

BCRP/ABCG2 in the placenta: expression, function and regulation

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

The ATP-binding cassette transporter ABCG2 (BCRP), a marker for side population stem cells, is expressed in human heart.

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Global analysis of genetic variation in SLCO1B1.

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Effect of OATP1B1 (SLCO1B1) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

SLCO1B1 (OATP1B1, an uptake transporter) and ABCG2 (BCRP, an efflux transporter) variant alleles and pharmacokinetics of pitavastatin in healthy volunteers

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Influence of OATP1B1 genotype on the pharmacokinetics of rosuvastatin in Koreans.

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Evidence for inverse effects of OATP-C (SLC21A6) 5 and 1b haplotypes on pravastatin kinetics

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Effect of genetic polymorphism of OATP-C (SLCO1B1) on lipid-lowering response to HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Acute effects of pravastatin on cholesterol synthesis are associated with SLCO1B1 (encoding OATP1B1) haplotype *17.

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Influence of the SLCO1B1*1b and *5 haplotypes on pravastatin's cholesterol lowering capabilities and basal sterol serum levels.

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Pharmacokinetics and response to pravastatin in paediatric patients with familial hypercholesterolaemia and in paediatric cardiac transplant recipients in relation to polymorphisms of the SLCO1B1 and ABCB1 genes

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

SLCO1B1 521T-->C functional genetic polymorphism and lipid-lowering efficacy of multiple-dose pravastatin in Chinese coronary heart disease patients

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

An association study of 43 SNPs in 16 candidate genes with atorvastatin response

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. Effect of patient characteristics on lovastatin-induced changes in plasma concentrations of lipids and lipoproteins

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Once-daily pravastatin in patients with primary hypercholesterolemia: a dose-response study

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

SLCO1B1 variants and statin-induced myopathy--a genomewide study

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Role of organic anion transporter OATP1B1 (OATP-C) in hepatic uptake of irinotecan and its active metabolite, 7-ethyl-10-hydroxycamptothecin: in vitro evidence and effect of single nucleotide polymorphisms.

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Severe toxicities after irinotecan-based chemotherapy in a patient with lung cancer: a homozygote for the SLCO1B1*15 allele

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Life-threatening toxicities in a patient with UGT1A1*6/*28 and SLCO1B1*15/*15 genotypes after irinotecan-based chemotherapy

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

The CYP2C8 inhibitor trimethoprim increases the plasma concentrations of repaglinide in healthy subjects

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Gemfibrozil considerably increases the plasma concentrations of rosiglitazone

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Gemfibrozil inhibits CYP2C8-mediated cerivastatin metabolism in human liver microsomes

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Gemfibrozil and its glucuronide inhibit the organic anion transporting polypeptide 2 (OATP2/OATP1B1:SLC21A6)-mediated hepatic uptake and CYP2C8-mediated metabolism of cerivastatin: analysis of the mechanism of the clinically relevant drug-drug inter

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Different effects of SLCO1B1 polymorphism on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinide

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Effect of SLCO1B1 genetic polymorphism on the pharmacokinetics of nateglinide

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Cyclosporine markedly raises the plasma concentrations of repaglinide

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Pharmacokinetic interaction between pravastatin and olmesartan in relation to SLCO1B1 polymorphism

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Reliability of the omeprazole hydroxylation index for CYP2C19 phenotyping: possible effect of age, liver disease and length of therapy

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

A CYP2D6 Phenotype-Genotype Mismatch in Japanese Psychiatric Patients

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Polymorphisms and linkage disequilibrium of the OATP8 (OATP1B3) gene in Japanese subjects.

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Variants in the SLCO1B3 gene: interethnic distribution and association with paclitaxel pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

High-dose methotrexate in pediatric acute lymphoblastic leukemia: impact of ABCC2 polymorphisms on plasma concentrations.

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

A mutation in the drug transporter gene ABCC2 associated with impaired methotrexate elimination

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Influence of SLCO1B1, 1B3, 2B1 and ABCC2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

C-440T/T-331C polymorphisms in the UGT1A9 gene affect the pharmacokinetics of mycophenolic acid in kidney transplantation

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes.

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy.

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

MRP2 haplotypes confer differential susceptibility to toxic liver injury

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Catalog of 605 single-nucleotide polymorphisms (SNPs) among 13 genes encoding human ATP-binding cassette transporters: ABCA4, ABCA7, ABCA8, ABCD1, ABCD3, ABCD4, ABCE1, ABCF1, ABCG1, ABCG2, ABCG4, ABCG5, and ABCG8

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine.

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta.

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Genetic variation in the ATP-binding Cassette Transporter gene ABCG2 (BCRP) in a Swedish population

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotype

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Effect of ABCG2 genotype on the oral bioavailability of topotecan

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Functional analysis of SNPs variants of BCRP/ABCG2.

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Transport of 7-ethyl-10-hydroxycamptothecin (SN-38) by breast cancer resistance protein ABCG2 in human lung cancer cells

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

ABCG2 pharmacogenetics: ethnic differences in allele frequency and assessment of influence on irinotecan disposition

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Involvement of multiple transporters in the hepatobiliary transport of rosuvastatin

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Sulfasalazine. Pharmacology, clinical use, toxicity, and related new drug development

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Breast cancer resistance protein (Bcrp/abcg2) is a major determinant of sulfasalazine absorption and elimination in the mouse

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Pharmacogenetic characterization of sulfasalazine disposition based on NAT2 and ABCG2 (BCRP) gene polymorphisms in humans

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Multidrug transporter ABCG2 prevents tumor cell death induced by the epidermal growth factor receptor inhibitor Iressa (ZD1839, Gefitinib).

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Association of variant ABCG2 and the pharmacokinetics of epidermal growth factor receptor tyrosine kinase inhibitors in cancer patients.

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Association of the BCRP C421A polymorphism with nonpapillary renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

BCRP gene polymorphisms are associated with susceptibility and survival of diffuse large B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Association of enzyme and transporter genotypes with the pharmacokinetics of imatinib

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

The effect of ABCG2 V12M, Q141K and Q126X, known functional variants in vitro, on the disposition of lamivudine

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Physiologically based pharmacokinetic modeling to predict transporter-mediated clearance and distribution of pravastatin in humans

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Transporters as a determinant of drug clearance and tissue distribution

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Organic anion transporting polypeptide 1B1 activity classified by SLCO1B1 genotype influences atrasentan pharmacokinetics

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Pharmacogenetics of cyclosporine in children suggests an age-dependent influence of ABCB1 polymorphisms

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Fexofenadine pharmacokinetics are associated with a polymorphism of the SLCO1B1 gene (encoding OATP1B1)

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Influence of the organic anion-transporting polypeptide 1B1 (OATP1B1) polymorphisms on irinotecan-pharmacokinetics and clinical outcome of patients with advanced non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

1199G>A and 2677G>T/A polymorphisms of ABCB1 independently affect tacrolimus concentration in hepatic tissue after liver transplantation

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Simvastatin does not influence the intestinal P-glycoprotein and MPR2, and the disposition of talinolol after chronic medication in healthy subjects genotyped for the ABCB1, ABCC2 and SLCO1B1 polymorphisms.

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

No significant effect of SLCO1B1 polymorphism on the pharmacokinetics of rosiglitazone and pioglitazone

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

A novel variant allele of OATP-C (SLCO1B1) found in a Japanese patient with pravastatin-induced myopathy.

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Irinotecan-induced diarrhea: functional significance of the polymorphic ABCC2 transporter protein

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in relation to ABC transporter genotypes

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Influence of ABCB1, ABCC1, ABCC2, and ABCG2 haplotypes on the cellular exposure of nelfinavir in vivo

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

OATP1B1 POLYMORPHISM IS A MAJOR DETERMINANT OF SERUM BILIRUBIN LEVEL BUT NOT ASSOCIATED WITH RIFAMPICIN-MEDIATED BILIRUBIN ELEVATION

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Different Effects of SLCO1B1 Polymorphism on the Pharmacokinetics of Atorvastatin and Rosuvastatin

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Impact of the SLCO1B1 polymorphism on the pharmacokinetics and lipid-lowering efficacy of multiple-dose pravastatin

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Effect of SLCO1B1 polymorphism on induction of CYP3A4 by rifampicin

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics

1 reference

https://api.crossref.org/works/10.1517%2F17425250902976854

21 January 2018

Identifiers

10.1517/17425250902976854

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

20 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37481450&oldid=2143633027"